FKBP4 and Alzheimer disease: To test this hypothesis, we have examined the levels of HSPs and their client proteins (HSP90, HSP70, HSP70, HSP60, HSP40, CDC37, P23, FKBP51, etc.)in HD, tauopathies, and AD animal models of neurodegenerative diseases.